| Phosphosite | Kinases | Tamoxifen | Reference |
| S46/47 | PKC | | [20] | Y52 | c-Abl | | [21] | S102/4/6 | GSK-3, ERK1/2 MAPK, CDK2 | Resistance | [20, 22–24] | S118 | CDK2, ERK1/2 MAPK, RAS/MAPK, GSK-3, CDK7, IKKα, mTOR/p70S6K | Dual effect | [18, 25–34] | S154 | | | [20] | S167 | ERK1/2 MAPK, p90RSK, CK2, Akt, mTOR/p70S6K | Sensitivity | [25, 30, 32, 34–39] | S212 | | | [20] | Y219 | c-Abl | | [21] | S236 | PKA | | [17, 32] | S282 | CK2 | Sensitivity | [20, 40, 41] | S294 | | | [20, 40] | S305 | PKA, PAK1? | Resistance | [15, 19, 32, 42–47] | T311 | RAS/MAPK | | [21, 40] | Y537 | Src Y kinases | Dual effect | [25, 32, 48–50] | S554 | | | [20] | S559 | CK2 | | [20, 41] |
|
|